Who invests in health supplement companies
Health supplements is a narrow tag, so the list is short: 200+ investors out of the 125,000+ in the Angel Match database. That works in your favor. You can read every profile and write each person a real reason to take your email, which beats blasting a list of thousands.
About half of these investors are based in the United States, with California and New York leading and Florida and Texas next. India comes second by country, then France and the United Kingdom. By city, New York City is first and Paris is second, followed by San Francisco and Austin. Austin shows up in the top four, so don't skip Texas.
Most of the list is individuals rather than firms. Angel investors carry the most common tag, on roughly two-thirds of the list. Venture capital is on about a third and private equity on about a quarter, though some investors carry more than one tag. That's a good fit for an early raise. Angels write checks of $25,000 to $500,000, while venture checks run from $2 million to $100 million or more.
Stage tags tell you where the list is deepest. Seed is the most common, followed by early stage venture. Pre-seed and Series B are tied well behind them, and Series A and late stage venture are thin too. If you have a formula and a brand but no sales yet, the pre-seed group is small, so it pays to get some early sales on the board before you reach out. That moves you into the much bigger seed group.
What these investors have in common
Look at the tags on the first page of results and a pattern shows up. Most of these investors are also tagged health care, and wellness, e-commerce, wearables and advertising come up again and again. That's a sample of the first 20 names, not a full count, but it shows how investors see the category. To them, supplements are a consumer health product sold online and built on marketing, not a lab-science business.
It also tells you where to widen your search. An investor who isn't tagged health supplements but is tagged wellness and e-commerce belongs on your list too, if their past investments include direct-to-consumer brands.
The French and US parts of the list look different, too. The Paris-based names on the first page are venture and private equity firms with dozens of market tags each, so supplements is one interest among many. The US names are mostly individual angels with shorter tag lists. For a Paris fund, show how your brand fits a broad consumer health thesis. For a US angel with a short tag list, lead with your story and your early numbers.
What supplement investors want to see
Demand is rarely the question. In a 2023 survey from the Council for Responsible Nutrition, 74% of U.S. adults said they take dietary supplements, and 55% counted as regular users. Investors already believe people buy supplements. What they need to believe is that you can reach buyers at a price that works and keep them coming back.
That's why repeat purchase is the number to lead with. Show what share of first-time buyers reorder within 90 days, how many are on a subscription, and what a customer is worth after a year. Then show what it costs you to win that customer. A CAC calculator helps you work out that second number before you put it in front of an investor.
Expect questions about the parts of the business that don't show up in your ad dashboard. Who makes your product, and could you switch manufacturers if you had to? Who owns the formula? Do you have third-party test results for every batch? How much of your revenue comes from your own site, and how much comes from a marketplace where someone else owns the customer? Having clean answers ready sets you apart.
The regulation questions to answer before they ask
Supplements are regulated differently from drugs, and first-time founders often get this wrong in both directions. The FDA has said it doesn't approve supplements before they reach shoppers, so you don't need a sign-off to launch. But you're not off the hook. If your label says your product supports a body function, like "supports immune health," you have to notify the FDA within 30 days of first selling it with that claim, and you need evidence to back the claim up. Claims about treating or preventing a disease are off the table.
There's a reporting rule, too. Brand owners have to send the FDA reports of serious adverse events within 15 business days. Investors will want to know you have a process for that, plus a manufacturer that follows good manufacturing practices. Put a one-page summary in your data room: the claims on your label, the evidence behind each one, who makes the product, and how you'd handle a customer complaint. If you plan to sell outside the U.S., add a line saying which market your label is built for, because the rules for what you can claim are different elsewhere.
How to work this list
Because the list is small, build it by hand. Start with U.S. investors tagged health supplements and either health care or wellness, and put the seed-stage names first. Then widen to wellness and e-commerce investors whose past investments include direct-to-consumer brands. Beyond New York City and Paris, most cities have fewer than a dozen names, so searching by state or country gives you more to work with than searching by a single city.
Use the overlap in your emails. If an investor is tagged supplements, e-commerce and advertising, they probably understand paid acquisition, so open with your payback period on ad spend. If they're tagged supplements and wearables, they may care about the data side of personalized nutrition, so open with that instead. One specific sentence that shows you read their profile does more than a polished paragraph about your brand.
India is second on the list by country, but check whether an investor backs brands outside their home market before you spend time on them. The same goes for France and the United Kingdom, where an investor may be set up around a different label and claims regime than yours.
A list this size lets you personalize every email. Start with the seed-stage investors in the United States who are tagged to health supplements and health care, write each one two lines that mention their other tags, and use our fundraising outreach email tool to get the first draft down. Then work outward to wellness and e-commerce investors with direct-to-consumer brands in their past investments.
Consumer health investors
